Parthenon Therapeutics
Incendia Therapeutics | Breaking Barriers to Better Cancer Treatment
Boston, United States · Founded 2019 · $65.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- incendiatx.com
- Total Funding
- $65.0M
- Last Round
- $65.0M Series ANov 2021
- Rounds
- 1
About
Precision oncology biotech developing novel therapies that reprogram the tumor microenvironment to fight cancer.
Summary
Parthenon Therapeutics is a Biotech company based in Boston, United States, founded in 2019. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Nov 2021. Investors include Northpond Ventures, Pfizer Ventures and Taiho Ventures.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2021
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/parthenon-therapeutics"><img src="https://indexed.vc/api/badge/company/parthenon-therapeutics" alt="Parthenon Therapeutics on Indexed.vc" width="260" height="76" /></a>